(Q84965607)

English

Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study

scientific article published on 20 September 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Michael Borte

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Isabella Quinti

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Annarosa Soresina

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Eduardo Fernández-Cruz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Bruce Ritchie

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Dirk S Schmidt

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Christine McCusker

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

20 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

952-961

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932110%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous administration of IgG.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immunoglobulin therapy for antibody deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunodeficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bioavailability of gamma-globulin after subcutaneous infusions in patients with common variable immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21932110

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84965607&oldid=2221688297"